Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 568
Filter
1.
Indian J Med Microbiol ; 48: 100522, 2024.
Article in English | MEDLINE | ID: mdl-38141828

ABSTRACT

A unique case report, probably first case from India, of lung abscess caused by Streptococcus intermedius in a previously untreated patient with Type 2 diabetes mellitus is reported here. The patient presented with non-productive cough and right-sided chest pain. Microbiological evaluation confirmed the presence of Streptococcus intermedius and the patient responded positively to antibiotic therapy. This case highlights the fact that S.intermedius may act as pathogen in immunocompromised individuals. So, a caution is needed by the medical fraternity before disregarding it as a commensal.


Subject(s)
Anti-Bacterial Agents , Lung Abscess , Streptococcal Infections , Streptococcus intermedius , Humans , India , Streptococcus intermedius/isolation & purification , Lung Abscess/microbiology , Lung Abscess/drug therapy , Lung Abscess/diagnosis , Streptococcal Infections/microbiology , Streptococcal Infections/diagnosis , Streptococcal Infections/drug therapy , Anti-Bacterial Agents/therapeutic use , Male , Diabetes Mellitus, Type 2/complications , Middle Aged , Radiography, Thoracic , Treatment Outcome , Tomography, X-Ray Computed
3.
Microbiol Spectr ; 10(1): e0097421, 2022 02 23.
Article in English | MEDLINE | ID: mdl-35171020

ABSTRACT

Pulmonary abscesses and pyothorax are bacterial infections believed to be caused primarily by oral microbes. However, past reports addressing such infections have not provided genetic evidence and lack accuracy, as they used samples that had passed through the oral cavity. The aim of this study was to determine whether genetically identical bacterial strains exist in both the oral microbiota and pus specimens that were obtained percutaneously from pulmonary abscesses and pyothorax, without oral contamination. First, bacteria isolated from pus were identified by 16S rRNA gene sequencing. It was then determined by quantitative PCR using bacterial-species-specific primers that DNA extracted from paired patient oral swab sample suspensions contained the same species. This demonstrated sufficient levels of bacterial DNA of the targeted species to use for further analysis in 8 of 31 strains. Therefore, the whole-genome sequences of these eight strains were subsequently determined and compared against an open database of the same species. Five strain-specific primers were synthesized for each of the eight strains. DNA extracted from the paired oral swab sample suspensions of the corresponding patients was PCR amplified using five strain-specific primers. The results provided strong evidence that certain pus-derived bacterial strains were of oral origin. Furthermore, this two-step identification process provides a novel method that will contribute to the study of certain pathogens of the microbiota. IMPORTANCE We present direct genetic evidence that some of the bacteria in pulmonary abscesses and pyothorax are derived from the oral flora. This is the first report describing the presence of genetically homologous strains both in pus from pulmonary abscesses and pyothorax and in swab samples from the mouth. We developed a new method incorporating quantitative PCR and next-generation sequencing and successfully prevented contamination of pus specimens with oral bacteria by percutaneous sample collection. The new genetic method would be useful for enabling investigations on other miscellaneous flora; for example, detection of pathogens from the intestinal flora at the strain level.


Subject(s)
Bacteria/genetics , Bacteria/isolation & purification , Empyema, Pleural/microbiology , Lung Abscess/microbiology , Microbiota , Mouth/microbiology , Adult , Aged , Bacteria/classification , Cohort Studies , DNA, Bacterial/genetics , Female , Humans , Male , Middle Aged , RNA, Ribosomal, 16S/genetics
7.
Anaerobe ; 69: 102325, 2021 Jun.
Article in English | MEDLINE | ID: mdl-33540111

ABSTRACT

OBJECTIVES: Lower respiratory tract infections (LRTIs) are often caused by the patient's own oral commensal bacteria. Causative bacteria must be identified to select the appropriate antimicrobial agents; however, the pathogens are identified via routine culture methods in only approximately half of LRTI cases. METHODS: To investigate LRTI-associated bacteria, we conducted culture testing under aerobic and anaerobic conditions using culture-independent partial 16S rRNA gene amplicon sequencing analysis using a high-throughput sequencer in cases of aspiration pneumonia and lung abscesses. RESULTS: Culture testing of 17 aspiration pneumonia cases revealed Streptococcus spp. (n = 13), Prevotella spp. (n = 9), and Veillonella spp. (n = 8); 16S rRNA analysis of these cases yielded Streptococcus spp. (n = 16), Veillonella spp. (n = 12), Haemophilus spp. (n = 12), Prevotella spp. (n = 11), and Rothia spp. (n = 11). Culture testing of 8 lung abscess cases revealed Streptococcus spp. (n = 7) and Fusobacterium spp. (n = 4); 16S rRNA analysis of these cases yielded Fusobacterium spp. (n = 8), Prevotella spp. (n = 7), Streptococcus spp. (n = 6), and Porphyromonas spp. (n = 5). All taxa with abundance ratios of ≥50% on the 16S rRNA analysis were also detected in the cultures. However, several taxa were either undetected in the cultures despite relatively high abundance ratios on the 16S rRNA analysis or negative on the 16S rRNA analysis and isolated only by culturing. CONCLUSION: Our data provide a comprehensive list of bacterial taxa that may be associated with aspiration pneumonia and lung abscesses. In empirically treating LRTIs, this information will help determine the best treatment against the targeted anaerobes.


Subject(s)
Bacteria, Anaerobic/genetics , Bacteria, Anaerobic/isolation & purification , Lung Abscess/microbiology , Mucus/microbiology , Nucleic Acid Amplification Techniques/methods , Pneumonia, Aspiration/microbiology , RNA, Ribosomal, 16S/isolation & purification , Humans
8.
BMC Pulm Med ; 21(1): 2, 2021 Jan 06.
Article in English | MEDLINE | ID: mdl-33407289

ABSTRACT

BACKGROUND: Congenital bronchial atresia is a rare pulmonary abnormality characterized by the disrupted communication between the central and the peripheral bronchus and is typically asymptomatic. Although it can be symptomatic especially when infections occur in the involved areas, fungal infections are rare complications in patients with bronchial atresia. We report a case of congenital bronchial atresia complicated by a fungal infection. CASE PRESENTATION: A 30-year-old man with no previous history of immune dysfunction was brought to a nearby hospital and diagnosed with a left lung abscess. Although antimicrobial treatment was administered, it was ineffective, and he was transferred to our hospital. Since diagnostic imaging findings and bronchoscopy suggested congenital bronchial atresia and a fungal infection, he was treated with voriconazole and surgical resection was subsequently performed. A tissue culture detected Aspergillus fumigatus and histopathological findings were compatible with bronchial atresia. After discharge, he remained well and voriconazole was discontinued 5 months after the initiation of therapy. CONCLUSION: Bronchial atresia is a rare disease that is seldom complicated by a fungal infection, which is also a rare complication; however, physicians should consider fungal infections in patients with bronchial atresia who present with infections resistant to antimicrobial treatment.


Subject(s)
Aspergillosis/microbiology , Aspergillus fumigatus/isolation & purification , Bronchi/abnormalities , Lung Abscess/microbiology , Respiratory System Abnormalities/complications , Adult , Aspergillosis/pathology , Aspergillosis/therapy , Bronchi/surgery , Bronchoscopy , Humans , Lung Abscess/pathology , Lung Abscess/surgery , Male , Radiography, Thoracic , Respiratory System Abnormalities/diagnosis , Tomography, X-Ray Computed , Voriconazole/therapeutic use
9.
Lupus ; 30(2): 347-351, 2021 Feb.
Article in English | MEDLINE | ID: mdl-33259737

ABSTRACT

Opportunistic infections are an ongoing concern in patients with autoimmune disease who are being treated with immunosuppressive agents. Nocardiosis is an uncommon opportunistic infection which has been reported in association with immunosuppressed patients and autoimmune disease. It is challenging to diagnose and can have multisystem manifestations. Failure to diagnose and appropriately treat can result in significant mortality. We present a 49 year old woman with systemic lupus erythematosus and neuromyelitis optica spectrum disorder who was treated with mycophenolate mofetil, prednisone and recent plasmapheresis. She developed acute onset of shortness of breath and fevers and was ultimately diagnosed with disseminated nocardiosis with lung, brain and muscle abscesses.


Subject(s)
Immunocompromised Host , Lupus Erythematosus, Systemic/complications , Neuromyelitis Optica/complications , Nocardia Infections/diagnosis , Nocardia Infections/drug therapy , Brain Abscess/diagnostic imaging , Brain Abscess/microbiology , Female , Humans , Imipenem/therapeutic use , Lung Abscess/diagnostic imaging , Lung Abscess/microbiology , Lupus Erythematosus, Systemic/therapy , Middle Aged , Mycophenolic Acid/therapeutic use , Neuromyelitis Optica/therapy , Plasmapheresis , Prednisone/therapeutic use , Radiography, Thoracic , Sulfamethoxazole/therapeutic use , Tomography, X-Ray Computed , Trimethoprim/therapeutic use
10.
Interact Cardiovasc Thorac Surg ; 31(6): 909-911, 2020 12 07.
Article in English | MEDLINE | ID: mdl-33155050

ABSTRACT

We report the case of a lung abscess due to Prevotella baroniae with a co-infection by Abiotrophia defective, which is a 'nutritionally variant streptococci' (NVS), in a 48-year-old patient. The delayed diagnosis of this co-infection led to multiple failures of medical treatment and need for surgery. Pathogenicity of these bacteria is well known, particularly in endocarditis, but not in lung infection. In pulmonary abscesses, co-infection with NVS is difficult to detect. It may explain some medical treatment failures. This case highlights the importance to systematically search for and consider NVS in such clinical contexts.


Subject(s)
Abiotrophia/isolation & purification , Coinfection , Delayed Diagnosis/adverse effects , Endocarditis, Bacterial/etiology , Gram-Positive Bacterial Infections/etiology , Lung Abscess/etiology , Lung/diagnostic imaging , Endocarditis , Endocarditis, Bacterial/diagnosis , Endocarditis, Bacterial/microbiology , Gram-Positive Bacterial Infections/diagnosis , Gram-Positive Bacterial Infections/microbiology , Humans , Lung/microbiology , Lung Abscess/diagnosis , Lung Abscess/microbiology , Male , Middle Aged , Tomography, X-Ray Computed
11.
BMJ Case Rep ; 13(9)2020 Sep 07.
Article in English | MEDLINE | ID: mdl-32900736

ABSTRACT

Prevotella genus comprises of obligate anaerobic, gram-negative bacteria that are commensal organisms of oral cavity, gut and vaginal mucosa. Although many Prevotella species have well-established pathogenicity with respect to pulmonary infections, rarely has Prevotella pleuritidis been isolated as a cause of lung abscess. We present a rare case of left lower lobe lung abscess due to P. pleuritidis identified using next-generation sequencing of microbial cell-free DNA testing. A brief review of the literature regarding Prevotella species pulmonary infections, use of next-generation cell-free DNA testing early in the evaluation, antibiotic susceptibility and resistance is also a part of this report.


Subject(s)
Bacteroidaceae Infections/complications , Lung Abscess/microbiology , Prevotella , Adult , Humans , Male
13.
Dtsch Med Wochenschr ; 145(16): 1145-1151, 2020 08.
Article in German | MEDLINE | ID: mdl-32791550

ABSTRACT

The new ATS/ERS/ESCMID/IDSA guideline answers 22 PICO questions on the treatment of lung diseases caused by Mycobacterium avium complex (MAC), M. kansasii, M. xenopi and M. abscessus. NON-TUBERCULOUS MYCOBACTERIA (NTM) LUNG DISEASE: Especially in patients with microscopic detection of acid-fast bacteria in sputum or with cavernous disease manifestation, the start of treatment should not be delayed. Treatment should be based on species-specific resistance testing (according to the CLSI guidelines). In selected patients, adjuvant surgical resection after consultation with an expert is recommended. MAC LUNG DISEASE: Therapy is based on a regimen with at least three drugs including a macrolide (rather azithromycin than clarithromycin) and ethambutol. For patients with cavitation, with pronounced nodular bronchiectatic disease or with macrolide resistance, daily oral therapy should be expanded by parenteral amikacin or streptomycin. Liposomally encapsulated amikacin for inhalation is recommended in patients with treatment failure. Patients with nodular-bronchiectatic disease manifestation should receive oral macrolide-based therapy, which - depending on the extent - can be given 3 times a week. The recommended duration is 12 months after conversion of the sputum culture. M. KANSASII LUNG DISEASE: The triple combination of rifampicin, ethambutol and macrolide (or isoniazid) is recommended for at least 12 months. In patients with rifampicin resistance or intolerance, moxifloxacin is recommended as a replacement. M. XENOPI LUNG DISEASE: The combination of rifampicin, ethambutol and macrolide (and/or moxifloxacin) is recommended for at least 12 months after conversion of the sputum culture. For patients with cavernous disease manifestation, it is recommended to add at least parenteral amikacin and to consult experts. M. ABSCESSUS LUNG DISEASE: At least 3, in the beginning rather 4 drugs are recommended for therapy. The choice of substance should be based on a in vitro resistance test. Macrolides are the basis, but should not be counted in patients with strains with inducible macrolide resistance. Due to the lack of data, no explicit recommendations are made regarding the duration of therapy; a consultation of experts is recommended.


Subject(s)
Anti-Bacterial Agents/therapeutic use , Mycobacterium Infections, Nontuberculous/drug therapy , Drug Administration Schedule , Drug Resistance, Microbial , Drug Therapy, Combination , Humans , Lung Abscess/drug therapy , Lung Abscess/microbiology , Mycobacterium Infections, Nontuberculous/diagnosis , Mycobacterium Infections, Nontuberculous/microbiology , Mycobacterium abscessus/drug effects , Mycobacterium avium Complex/drug effects , Mycobacterium kansasii/drug effects , Mycobacterium xenopi/drug effects
14.
Eur J Clin Microbiol Infect Dis ; 39(12): 2327-2334, 2020 Dec.
Article in English | MEDLINE | ID: mdl-32666483

ABSTRACT

To report the first case of a lung abscess caused by Neisseria meningitidis (Nm) and to genetically characterize the rare underlying capsule switching event. The strain (PT NmX) was subjected to whole genome sequencing, and a comparative gene-by-gene analysis was performed based on 1605 N. meningitidis core loci that constitute the MLST core-genome scheme (cgMLST) V1.0. All ~ 9,600 genomes available on Neisseria PubMLST (until 30th November 2019) from all serogroups were used to better identify the genome make-up of the PT NmX strain. This strain was found to be highly divergent from other NmX reported worldwide and to belong to a new sequence type (ST-14273), with the finetype X: P1.19,15-1:F5-2. Moreover, it revealed a closer genetic proximity to strains from serogroup B than to other serogroups, suggesting a genome backbone associated with serogroup B, while it presents a capsule synthesis region derived from a NmX strain. We describe a new hybrid NmB/X isolate from a noninvasive meningococcal infection, causing lung abscess. Despite capsular switching events involving serogroup X are rare, it may lead to the emergence of pathogenic potential. Studies should continue to better understand the molecular basis underlying Neisseria strains' ability to spread to body compartments other than the tissues for which their tropism is already known.


Subject(s)
Bacterial Capsules/genetics , Lung Abscess/microbiology , Meningococcal Infections/microbiology , Neisseria meningitidis/genetics , Neisseria meningitidis/isolation & purification , Humans , Lung Abscess/diagnosis , Male , Meningococcal Infections/diagnosis , Middle Aged , Multilocus Sequence Typing , Neisseria meningitidis, Serogroup B/genetics , Serotyping , Virulence , Whole Genome Sequencing
15.
BMC Infect Dis ; 20(1): 389, 2020 Jun 01.
Article in English | MEDLINE | ID: mdl-32487026

ABSTRACT

BACKGROUND: Intracranial infections with Corynebacterium striatum (C. striatum) have been described sporadically in the literature over the last two decades. However, C. striatum meningitis combined with multiple abscesses has not been published before. CASE PRESENTATION: In this report, we describe the clinical and imaging findings in a 54-year-old woman with meningitis caused by C. striatum and combined with suspected brain and lung abscesses. This patient who underwent multiple fractures and a recent cut presented with headache and paraphasia. C. striatum was isolated in cerebrospinal fluid and supposedly transmitted from the skin purulent wound through blood. The patient was treated with intravenous vancomycin and had a transient improvement, but died finally. Multiple abscesses, especially in the brain, could be a reason to explain her conditions were deteriorating rapidly. CONCLUSIONS: Note that C. striatum can cause life-threatening infections. Early identification and diagnosis, early administration of antibiotics to which the bacterium is susceptible, and treatment of complications will be beneficial in patients with C. striatum-related infection.


Subject(s)
Brain Abscess/microbiology , Corynebacterium Infections/complications , Lung Abscess/microbiology , Meningitis, Bacterial/microbiology , Anti-Bacterial Agents/therapeutic use , Brain Abscess/diagnostic imaging , Brain Abscess/drug therapy , Cerebrospinal Fluid/microbiology , Corynebacterium/isolation & purification , Corynebacterium/pathogenicity , Corynebacterium Infections/drug therapy , Female , Humans , Leg Injuries/microbiology , Lung Abscess/diagnostic imaging , Lung Abscess/drug therapy , Meningitis, Bacterial/complications , Meningitis, Bacterial/drug therapy , Middle Aged , Vancomycin/therapeutic use
16.
BMC Infect Dis ; 20(1): 351, 2020 May 18.
Article in English | MEDLINE | ID: mdl-32423417

ABSTRACT

BACKGROUND: Eikenella corrodens and Streptococcus anginosus, which are primary colonization bacteria of the normal flora of the oropharynx, are infrequent bacteria, especially the former. Here, we report a case of lung abscess with a coinfection of Eikenella corrodens and Streptococcus anginosus in a lung cancer patient. CASE PRESENTATION: A 66-year-old Chinese man with lung cancer was admitted to the hospital, complaining of a cough and expectoration for five months and fever for two months. After a series of inspections to differentiate a cancer-related fever from an infectious fever, he was diagnosed with lung abscess. Draining pus culture demonstrated Eikenella corrodens and Streptococcus anginosus. After more than 1 month of antibiotic therapy and draining in total, he gradually recovered to fight against lung cancer. CONCLUSION: This report highlights the increased pathogenicity of Eikenella corrodens and Streptococcus anginosus in an immunocompromised cancer patient, especially after a few invasive operations. Additionally, even though a patient has been diagnosed with cancerous fever, strong vigilance is needed in case an infection arises.


Subject(s)
Coinfection/diagnosis , Eikenella corrodens/isolation & purification , Gram-Negative Bacterial Infections/diagnosis , Lung Abscess/microbiology , Lung Neoplasms/complications , Streptococcal Infections/diagnosis , Streptococcus anginosus/isolation & purification , Aged , Anti-Bacterial Agents/therapeutic use , Coinfection/drug therapy , Drainage , Fever/drug therapy , Gram-Negative Bacterial Infections/drug therapy , Gram-Negative Bacterial Infections/microbiology , Humans , Lung Abscess/drug therapy , Male , Streptococcal Infections/drug therapy , Streptococcal Infections/microbiology , Treatment Outcome
17.
Rev Mal Respir ; 37(5): 417-421, 2020 May.
Article in French | MEDLINE | ID: mdl-32360054

ABSTRACT

INTRODUCTION: IgA vasculitis is a leucocytoclastic vasculitis of small vessels with immune deposits of IgA. It tends to occur in a post-infectious context, though the pathogenic agent is rarely found. OBSERVATION: We report, for the first time, the case of an 81-year old patient who presented with an acute IgA vasculitis with cutaneous and joint involvement during a Klebsiella pneumoniae respiratory infection. Remission of vasculitis was observed after antibiotic therapy alone. CONCLUSION: This observation reminds us of the need to search carefully for any pathogenic agent that may be driving IgA vasculitis as this may be important both for understanding aetiology and for treatment.


Subject(s)
Immunoglobulin A/adverse effects , Klebsiella Infections/complications , Klebsiella pneumoniae/physiology , Pneumonia, Bacterial/complications , Vasculitis/etiology , Aged, 80 and over , Humans , Klebsiella Infections/immunology , Klebsiella pneumoniae/immunology , Lung Abscess/complications , Lung Abscess/immunology , Lung Abscess/microbiology , Male , Pneumonia, Bacterial/immunology , Pneumonia, Bacterial/microbiology , Vasculitis/diagnosis , Vasculitis, Leukocytoclastic, Cutaneous/diagnosis , Vasculitis, Leukocytoclastic, Cutaneous/etiology , Vasculitis, Leukocytoclastic, Cutaneous/immunology
18.
Int J Syst Evol Microbiol ; 70(3): 1758-1768, 2020 Mar.
Article in English | MEDLINE | ID: mdl-32228771

ABSTRACT

We describe a new multidrug resistant Chitinophaga species that was isolated from patients with type 2 diabetes in Vietnam. Strain BD 01T was cultivated in 2017 from a blood sample of a patient suffering from bacteremia. Strain VP 7442 was isolated in 2018 from a pleural fluid sample of a patient who had presented with lung abscess and pleural effusion. Both strains are aerobic, Gram-negative, non-motile and non-spore-forming. The 16S rRNA gene sequences of both strains are 100 % similar and share a highest 16S sequence identity with Chitinophaga polysaccharea MRP-15T of 97.42 %. Their predominant fatty acid is iso-C15 : 0 (73.8 % for strain BD 01T and 79.8 % for strain VP 7442). The draft genome sizes of strains BD 01T and VP 7442 are 6 308 408 and 6 308 579 bp, respectively. They are resistant to beta-lactams, aminoglycosides, fluoroquinolones, metronidazole, fosfomycin, vancomycin and macrolides, and exhibit 20 and 18 antimicrobial resistance-related genes, respectively. Using the multiphasic taxonogenomic approach, we propose that strains BD 01T (=CSUR P9622=VTCC 70981) and VP 7442 (=CSUR P9623=VTCC 70982) represent a new species, for which we propose the name Chitinophaga vietnamensis sp. nov. Strain BD 01T was chosen as type strain of C. vietnamensis sp. nov.


Subject(s)
Bacteroidetes/classification , Drug Resistance, Multiple, Bacterial , Phylogeny , Bacteremia , Bacterial Typing Techniques , Bacteroidetes/isolation & purification , Base Composition , DNA, Bacterial/genetics , Diabetes Mellitus, Type 2 , Fatty Acids/chemistry , Humans , Lung Abscess/microbiology , RNA, Ribosomal, 16S/genetics , Sequence Analysis, DNA , Vietnam
19.
WMJ ; 119(1): 62-65, 2020 Mar.
Article in English | MEDLINE | ID: mdl-32348075

ABSTRACT

INTRODUCTION: Methicillin-resistant staphylococcus aureus (MRSA) bacteremia is a life-threatening illness and a major global health care problem. It can cause metastatic and complicated infections. CASE PRESENTATION: A 58-year-old man with uncontrolled type 2 diabetes mellitus presented with altered mental status after a fall. He was found to have a hip fracture, diabetic ketoacidosis, and MRSA bacteremia. This was complicated by septic knee arthritis, prostatic abscess, intraretinal abscess, periapical abscesses, and pulmonary abscesses. He was treated with intravenous vancomycin and oral linezolid and eventually recovered. DISCUSSION: Severe metastatic MRSA infection was likely due, in part, to the patient's uncontrolled diabetes, as he has no underlying immunodeficiency and was HIV negative. Prostatic abscesses are a relatively rare occurrence that typically develop in immunocompromised patients. CONCLUSION: This case is an interesting confluence of sequelae of MRSA bacteremia and reinforces the necessity for clinicians to be diligent when evaluating a patient with a suspected prostatic abscess.


Subject(s)
Abscess/microbiology , Arthritis, Infectious/microbiology , Sepsis/microbiology , Staphylococcal Infections/drug therapy , Staphylococcal Infections/microbiology , Abscess/drug therapy , Accidental Falls , Anti-Bacterial Agents/therapeutic use , Arthritis, Infectious/drug therapy , Diabetes Mellitus, Type 2/complications , Humans , Linezolid/therapeutic use , Lung Abscess/drug therapy , Lung Abscess/microbiology , Male , Methicillin-Resistant Staphylococcus aureus , Middle Aged , Periapical Abscess/drug therapy , Periapical Abscess/microbiology , Prostatitis/drug therapy , Prostatitis/microbiology , Retinal Diseases/drug therapy , Retinal Diseases/microbiology , Sepsis/drug therapy , Vancomycin/therapeutic use
20.
BMC Pediatr ; 20(1): 98, 2020 03 02.
Article in English | MEDLINE | ID: mdl-32122323

ABSTRACT

BACKGROUND: Enterococci are rarely considered pulmonary pathogens; they are usually regarded as colonizers of the airway. The authors present the case of a previously healthy male adolescent, with complaints of fatigue and chest pain, who was diagnosed with Enterococcus faecalis-associated acute primary lung abscess. CASE PRESENTATION: A previously healthy 17-year old boy was admitted to the pediatric ward due to a one-week history of fatigue, inspiratory left side chest pain, dry cough and nasal obstruction. On admission at the emergency department, he was afebrile, with no signs of respiratory distress, but with diminished breath sounds on the left side. A chest x-ray showed a round opacity on the posterior basal segment of the left lower lobe; he was discharged with oral amoxicillin 1000 mg three times a day with the diagnosis of community-acquired pneumonia. Due to the worsening of the productive cough with purulent stinking sputum he was re-evaluated after 4 days. Laboratory studies showed a leukocyte count of 15200/uL and a c-reactive protein of 172 mg/l. The chest computed tomography scan was suggestive of a consolidation of the left lower lobe base and a central abscess. An intravenous course of ceftriaxone and clindamycin was initiated, with a favourable clinical evolution. The bronchofibroscopy performed on day four after his admission revealed the presence of a tracheal bronchus and numerous purulent secretions. Culture examination of bronchoalveolar lavage fluid samples was positive (> 10^5) for Enterococcus faecalis. No complications were registered during his stay in the pediatric ward. He was discharged after a 14-day course of intravenous ceftriaxone and clindamycin, with the recommendation to complete a four-week course of oral amoxicillin/clavulanic acid. On his reevaluation 4 weeks after his discharge, he was asymptomatic. CONCLUSION: This case report highlights the importance of considering Enterococcus faecalis as an etiologic agent in cases of non-resolving or complicated cases of pneumonia, such as lung abscesses, even in young patients with no comorbidities or risk factors.


Subject(s)
Gram-Positive Bacterial Infections , Lung Abscess , Pneumonia , Adolescent , Anti-Bacterial Agents/therapeutic use , Clindamycin/therapeutic use , Enterococcus faecalis/isolation & purification , Gram-Positive Bacterial Infections/diagnosis , Gram-Positive Bacterial Infections/drug therapy , Humans , Lung Abscess/diagnosis , Lung Abscess/drug therapy , Lung Abscess/microbiology , Male , Pneumonia/drug therapy
SELECTION OF CITATIONS
SEARCH DETAIL
...